110 related articles for article (PubMed ID: 1997157)
1. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma.
Murnane MJ; Sheahan K; Ozdemirli M; Shuja S
Cancer Res; 1991 Feb; 51(4):1137-42. PubMed ID: 1997157
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
4. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
5. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy.
Husain I; Mohler JL; Seigler HF; Besterman JM
Cancer Res; 1994 Jan; 54(2):539-46. PubMed ID: 8275492
[TBL] [Abstract][Full Text] [Related]
6. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues.
Qian F; Bajkowski AS; Steiner DF; Chan SJ; Frankfater A
Cancer Res; 1989 Sep; 49(17):4870-5. PubMed ID: 2758418
[TBL] [Abstract][Full Text] [Related]
7. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.
Liabakk NB; Talbot I; Smith RA; Wilkinson K; Balkwill F
Cancer Res; 1996 Jan; 56(1):190-6. PubMed ID: 8548762
[TBL] [Abstract][Full Text] [Related]
10. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
11. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors.
Qian F; Chan SJ; Gong QM; Bajkowski AS; Steiner DF; Frankfater A
Biomed Biochim Acta; 1991; 50(4-6):531-40. PubMed ID: 1801719
[TBL] [Abstract][Full Text] [Related]
12. [Expression of cathepsin B and its clinical importance in colorectal cancer].
Yu B; Li SY; An P; Zuo FY; Cai HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
14. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
15. Gene expression in colorectal cancer.
Birkenkamp-Demtroder K; Christensen LL; Olesen SH; Frederiksen CM; Laiho P; Aaltonen LA; Laurberg S; Sørensen FB; Hagemann R; ØRntoft TF
Cancer Res; 2002 Aug; 62(15):4352-63. PubMed ID: 12154040
[TBL] [Abstract][Full Text] [Related]
16. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
17. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.
Abe N; Watanabe T; Sugiyama M; Uchimura H; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 1999 Mar; 59(6):1169-74. PubMed ID: 10096541
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
19. Evidence that E-box promoter elements and MyoD transcription factors play a role in the induction of cathepsin B gene expression during human myoblast differentiation.
Jane DT; Morvay LC; Koblinski J; Yan S; Saad FA; Sloane BF; Dufresne MJ
Biol Chem; 2002 Dec; 383(12):1833-44. PubMed ID: 12553720
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
Kos J; Nielsen HJ; Krasovec M; Christensen IJ; Cimerman N; Stephens RW; Brünner N
Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
